Literature DB >> 7803350

Effect of diabetes associated increases in lens optical density on colour discrimination in insulin dependent diabetes.

K J Hardy1, J H Scarpello, D H Foster, J D Moreland.   

Abstract

Optical density (OD) of the crystalline lens has been shown in non-diabetics to increase linearly with age over the first five decades and at an increased rate thereafter; in insulin dependent diabetic (IDDM) patients, lens OD increases with age and with duration of diabetes at a rate similar to that in non-diabetics over the age of 60 years. Recently, it has been established that colour discrimination is abnormal in a majority of young patients with uncomplicated IDDM and angiographically normal retinas. Colour discrimination loss was attributed to functional abnormalities in the retina or neural pathways; yet the possibility exists that increases in lens OD may account for part or all of the colour discrimination loss in IDDM. In the present study, colour discrimination was compared in aretinopathic IDDM patients and age-matched controls, and then in a group of aretinopathic IDDM patients individually matched to controls with respect to lens OD. Colour discrimination was significantly worse in diabetic patients than in age-matched controls, and was significantly worse when diabetic patients were compared with controls matched for OD. The magnitude of the difference in 100 hue error score between diabetic patients and OD matched controls was, however, considerably less than the difference between diabetic patients and age-matched controls. These data suggest that colour discrimination loss in aretinopathic IDDM patients cannot be explained solely on the basis of diabetes induced increases in lens OD, but must involve abnormalities of the retina or its neural connections.

Entities:  

Mesh:

Year:  1994        PMID: 7803350      PMCID: PMC504928          DOI: 10.1136/bjo.78.10.754

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  The variation with age of the spectral transmissivity of the living human crystalline lens.

Authors:  F S SAID; R A WEALE
Journal:  Gerontologia       Date:  1959

2.  Proposals for scoring and assessing the 100-Hue test.

Authors:  P R Kinnear
Journal:  Vision Res       Date:  1970-05       Impact factor: 1.886

3.  Biometry of the crystalline lens in early-onset diabetes.

Authors:  J M Sparrow; A J Bron; N A Brown; H A Neil
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

4.  Lens-equivalent age controls for diabetics.

Authors:  J D Moreland
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-02       Impact factor: 4.799

5.  A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores.

Authors:  G Verriest; J Van Laethem; A Uvijls
Journal:  Am J Ophthalmol       Date:  1982-05       Impact factor: 5.258

6.  The effect of age upon colour vision. II. Changes with age in light transmission of the ocular media.

Authors:  K H Ruddock
Journal:  Vision Res       Date:  1965-01       Impact factor: 1.886

7.  Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas.

Authors:  K J Hardy; J Lipton; M O Scase; D H Foster; J H Scarpello
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

8.  Lenses of diabetic patients "yellow" at an accelerated rate similar to older normals.

Authors:  M Lutze; G H Bresnick
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-01       Impact factor: 4.799

9.  Lens transmission of blue-green light in diabetic patients as measured by autofluorophotometry.

Authors:  J A van Best; L Vrij; J A Oosterhuis
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-04       Impact factor: 4.799

10.  Clinical photon correlation spectroscopy evaluation of human diabetic lenses.

Authors:  S E Bursell; R S Baker; J N Weiss; J F Haughton; L I Rand
Journal:  Exp Eye Res       Date:  1989-08       Impact factor: 3.467

  10 in total
  7 in total

1.  Risk factors associated with contrast sensitivity loss in diabetic patients.

Authors:  A A Dosso; E R Bonvin; Y Morel; A Golay; J P Assal; P M Leuenberger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

2.  Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.

Authors:  Yanling Liu; Lan Franco Leo; Corban McGregor; Anzor Grivitishvili; Colin J Barnstable; Joyce Tombran-Tink
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

3.  Diabetic versus non-diabetic colour vision after cataract surgery.

Authors:  L Kessel; A Alsing; M Larsen
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

4.  Extent of foveal tritanopia in diabetes mellitus.

Authors:  N Davies; A Morland
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

5.  Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision.

Authors:  G L Ong; L G Ripley; R S B Newsom; A G Casswell
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

6.  Early visual deficits in streptozotocin-induced diabetic long evans rats.

Authors:  Moe H Aung; Moon K Kim; Darin E Olson; Peter M Thule; Machelle T Pardue
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-15       Impact factor: 4.799

7.  Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy.

Authors:  Phillip A Vanlandingham; Didier J Nuno; Alexander B Quiambao; Eric Phelps; Ronald A Wassel; Jian-Xing Ma; Krysten M Farjo; Rafal A Farjo
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.